Literature DB >> 6488591

Inhibition of in vitro lymphocyte proliferation by serum from acquired immune deficiency syndrome patients depends on the ratio of cells to serum in culture.

A K Hennig, R H Tomar.   

Abstract

The effect of serum from patients with acquired immune deficiency syndrome (AIDS) on cultures of normal human peripheral blood mononuclear cells stimulated with phytohemagglutinin (PHA) has been studied. It has been found that AIDS sera are inhibitory when compared with control sera from healthy individuals. The inhibitory activity in the AIDS patients' sera is dilutable with normal serum, is dependent on the number of cells present in culture and the amount of serum added, and cannot be attributed to a deficiency of nutrients in these sera. Inhibition of proliferation occurs even when AIDS serum is added to cultures of normal cells several hours after stimulation with PHA. In one patient who was being treated with plasmapheresis, decreases in serum inhibitory activity were found after pheresis procedures and were coincident with increases in the number of circulating T4-positive lymphocytes.

Entities:  

Mesh:

Year:  1984        PMID: 6488591     DOI: 10.1016/0090-1229(84)90080-1

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  5 in total

1.  Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression.

Authors:  R P Donnelly; M F La Via; K Y Tsang
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

2.  Inhibition of interleukin-2-induced T-cell proliferation by sera from patients with the acquired immune deficiency syndrome.

Authors:  R P Donnelly; K Y Tsang; G M Galbraith; J I Wallace
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

3.  Serum immunomodulatory factors in gastrointestinal diseases. A 30-50-kD serum fraction in Crohn's disease capable of modulating lymphocyte activation.

Authors:  L Biancone; M Boirivant; S Fais; G L Ricci; R Paganelli; F Pallone
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

4.  Specificity of anti-lymphocyte antibodies in sera from patients with AIDS-related complex (ARC) and healthy homosexuals.

Authors:  R Q Warren; E A Johnson; R P Donnelly; M F Lavia; K Y Tsang
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

5.  Reversal of immunosuppression of lymphocyte proliferation caused by sera from persons with AIDS.

Authors:  R H Tomar; P John; P Hinds
Journal:  Clin Diagn Lab Immunol       Date:  1995-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.